Skip to Main Content

Paper Details

Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer.
Clin Cancer Res
36
2021
Author NameAffiliation
Ilsa ColemanFred Hutchinson Cancer Research Center
Eva CoreyUniversity of Washington School of Medicine
Lawrence D TrueUniversity of Washington School of Medicine
Michael C HaffnerFred Hutchinson Cancer Research Center
Michael C HaffnerClinical Research Division, Fred Hutchinson Cancer Research Center
Michael C HaffnerUniversity of Washington School of Medicine
Colm MorrisseyUniversity of Washington School of Medicine
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington School of Medicine
Peter S NelsonClinical Research Division, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington School of Medicine
Peter S NelsonUniversity of Washington School of Medicine
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington School of Medicine
Peter S NelsonClinical Research Division, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington School of Medicine
Peter S NelsonUniversity of Washington School of Medicine
  • 1 - 17

Datasets